+127.5%
CURE price history and return analytics
+74.1%
+53.4%
-51.9%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | VT | Excess | Alpha |
|---|---|---|---|---|
| 1D | +6.0% | +2.6% | +3.4% | +2.4% |
| 7D | +5.6% | +0.4% | +5.2% | +5.5% |
| 30D | +31.2% | -2.6% | +33.8% | +36.1% |
| 3M | +41.0% | -3.2% | +44.2% | +47.5% |
| 6M | +109.2% | +0.9% | +108.3% | +102.6% |
| YTD | +59.3% | +11.3% | +48.0% | +31.6% |
| 1Y | +87.5% | +14.0% | +73.5% | +49.1% |
| 3Y | +127.5% | +75.8% | +51.6% | +0.4% |
| All | +127.5% | +74.1% | +53.4% | +0.4% |
Cumulative growth
Daily Returns
Daily percentage return beside VT.
Daily Out/Under-Performance
Portfolio return minus VT return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × VT return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded VT wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling